• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于机器学习的低级别胶质瘤干性亚型鉴定可区分患者预后和药物反应。

Machine learning-based identification of lower grade glioma stemness subtypes discriminates patient prognosis and drug response.

作者信息

Zhou Hongshu, Chen Bo, Zhang Liyang, Li Chuntao

机构信息

Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan, PR China.

Hypothalamic-pituitary Research Center, Xiangya Hospital, Central South University, Changsha, Hunan, PR China.

出版信息

Comput Struct Biotechnol J. 2023 Jul 22;21:3827-3840. doi: 10.1016/j.csbj.2023.07.029. eCollection 2023.

DOI:10.1016/j.csbj.2023.07.029
PMID:37560125
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10407594/
Abstract

Glioma stem cells (GSCs) remodel their tumor microenvironment to sustain a supportive niche. Identification and stratification of stemness related characteristics in patients with glioma might aid in the diagnosis and treatment of the disease. In this study, we calculated the mRNA stemness index in bulk and single-cell RNA-sequencing datasets using machine learning methods and investigated the correlation between stemness and clinicopathological characteristics. A glioma stemness-associated score (GSScore) was constructed using multivariate Cox regression analysis. We also generated a GSC cell line derived from a patient diagnosed with glioma and used glioma cell lines to validate the performance of the GSScore in predicting chemotherapeutic responses. Differentially expressed genes (DEGs) between GSCs with high and low GSScores were used to cluster lower-grade glioma (LGG) samples into three stemness subtypes. Differences in clinicopathological characteristics, including survival, copy number variations, mutations, tumor microenvironment, and immune and chemotherapeutic responses, among the three LGG stemness-associated subtypes were identified. Using machine learning methods, we further identified genes as subtype predictors and validated their performance using the CGGA datasets. In the current study, we identified a GSScore that correlated with LGG chemotherapeutic response. Through the score, we also identified a novel classification of the LGG subtype and associated subtype predictors, which might facilitate the development of precision therapy.

摘要

胶质瘤干细胞(GSCs)重塑其肿瘤微环境以维持支持性生态位。识别和分层胶质瘤患者中与干性相关的特征可能有助于该疾病的诊断和治疗。在本研究中,我们使用机器学习方法计算了批量和单细胞RNA测序数据集中的mRNA干性指数,并研究了干性与临床病理特征之间的相关性。使用多变量Cox回归分析构建了胶质瘤干性相关评分(GSScore)。我们还从一名被诊断患有胶质瘤的患者中生成了一个GSC细胞系,并使用胶质瘤细胞系验证GSScore在预测化疗反应方面的性能。将高GSScore和低GSScore的GSCs之间的差异表达基因(DEGs)用于将低级别胶质瘤(LGG)样本聚类为三种干性亚型。确定了三种LGG干性相关亚型在临床病理特征方面的差异,包括生存、拷贝数变异、突变、肿瘤微环境以及免疫和化疗反应。使用机器学习方法,我们进一步将基因鉴定为亚型预测因子,并使用CGGA数据集验证了它们的性能。在当前研究中,我们确定了一个与LGG化疗反应相关的GSScore。通过该评分,我们还确定了LGG亚型的一种新分类以及相关的亚型预测因子,这可能有助于精准治疗的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e0/10407594/063685ffc9a6/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e0/10407594/33467c0d807c/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e0/10407594/d53cdf6f396e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e0/10407594/084c7937e138/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e0/10407594/079730ea8e45/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e0/10407594/8828ce1a91d3/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e0/10407594/804f1e78def7/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e0/10407594/acb580d8b6e8/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e0/10407594/6177f78f0c93/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e0/10407594/063685ffc9a6/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e0/10407594/33467c0d807c/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e0/10407594/d53cdf6f396e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e0/10407594/084c7937e138/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e0/10407594/079730ea8e45/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e0/10407594/8828ce1a91d3/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e0/10407594/804f1e78def7/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e0/10407594/acb580d8b6e8/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e0/10407594/6177f78f0c93/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e0/10407594/063685ffc9a6/gr8.jpg

相似文献

1
Machine learning-based identification of lower grade glioma stemness subtypes discriminates patient prognosis and drug response.基于机器学习的低级别胶质瘤干性亚型鉴定可区分患者预后和药物反应。
Comput Struct Biotechnol J. 2023 Jul 22;21:3827-3840. doi: 10.1016/j.csbj.2023.07.029. eCollection 2023.
2
Integrated analysis of inflammatory response subtype-related signature to predict clinical outcomes, immune status and drug targets in lower-grade glioma.炎症反应亚型相关特征的综合分析,用于预测低级别胶质瘤的临床结局、免疫状态和药物靶点。
Front Pharmacol. 2022 Aug 26;13:914667. doi: 10.3389/fphar.2022.914667. eCollection 2022.
3
Stemness subtypes in lower-grade glioma with prognostic biomarkers, tumor microenvironment, and treatment response.低级别胶质瘤的干性亚型与预后生物标志物、肿瘤微环境和治疗反应。
Sci Rep. 2024 Jun 26;14(1):14758. doi: 10.1038/s41598-024-65717-7.
4
Prognostic Value of a Stemness Index-Associated Signature in Primary Lower-Grade Glioma.干性指数相关特征在原发性低级别胶质瘤中的预后价值
Front Genet. 2020 May 5;11:441. doi: 10.3389/fgene.2020.00441. eCollection 2020.
5
Elucidating the Role of Pyroptosis in Lower-Grade Glioma: Development of a Novel Scoring System to Enhance Personalized Therapeutic Approaches.阐明细胞焦亡在低级别胶质瘤中的作用:建立一种新的评分系统以增强个性化治疗方法。
J Mol Neurosci. 2023 Aug;73(7-8):649-663. doi: 10.1007/s12031-023-02147-6. Epub 2023 Aug 11.
6
Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.TYROBP 表达升高预示低级别胶质瘤患者预后不良和肿瘤免疫浸润程度高。
BMC Cancer. 2021 Jun 23;21(1):723. doi: 10.1186/s12885-021-08456-6.
7
Machine learning-identified stemness features and constructed stemness-related subtype with prognosis, chemotherapy, and immunotherapy responses for non-small cell lung cancer patients.机器学习鉴定的干性特征和构建的与干性相关的亚组,用于预测非小细胞肺癌患者的预后、化疗和免疫治疗反应。
Stem Cell Res Ther. 2023 Sep 7;14(1):238. doi: 10.1186/s13287-023-03406-4.
8
Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma.用于低级别胶质瘤生存风险分层和预后的新型免疫相关基因特征
Front Genet. 2020 Apr 15;11:363. doi: 10.3389/fgene.2020.00363. eCollection 2020.
9
Molecular Subtypes Based on the Stemness Index Predict Prognosis in Glioma Patients.基于干性指数的分子亚型预测胶质瘤患者的预后。
Front Genet. 2021 Mar 1;12:616507. doi: 10.3389/fgene.2021.616507. eCollection 2021.
10
Characterization of stemness features and construction of a stemness subtype classifier to predict survival and treatment responses in lung squamous cell carcinoma.干性特征的表征和干性亚型分类器的构建,以预测肺鳞状细胞癌的生存和治疗反应。
BMC Cancer. 2023 Jun 8;23(1):525. doi: 10.1186/s12885-023-10918-y.

引用本文的文献

1
Integration of Multi-omics Data Based on Deep Learning for Subtyping of Low-Grade Glioma.基于深度学习的多组学数据整合用于低级别胶质瘤的亚型分类
J Mol Neurosci. 2025 Aug 27;75(3):110. doi: 10.1007/s12031-025-02393-w.
2
Nanofibers in Glioma Therapy: Advances, Applications, and Overcoming Challenges.神经胶质瘤治疗中的纳米纤维:进展、应用及挑战应对
Int J Nanomedicine. 2025 Apr 14;20:4677-4703. doi: 10.2147/IJN.S510363. eCollection 2025.
3
A data-centric machine learning approach to improve prediction of glioma grades using low-imbalance TCGA data.

本文引用的文献

1
A pathway-based mutation signature to predict the clinical outcomes and response to CTLA-4 inhibitors in melanoma.一种基于通路的突变特征,用于预测黑色素瘤的临床结局及对CTLA-4抑制剂的反应。
Comput Struct Biotechnol J. 2023 Apr 11;21:2536-2546. doi: 10.1016/j.csbj.2023.04.004. eCollection 2023.
2
Dynamic gene screening enabled identification of a 10-gene panel for early detection and progression assessment of gastric cancer.动态基因筛查有助于识别一个用于胃癌早期检测和病情进展评估的10基因组合。
Comput Struct Biotechnol J. 2022 Dec 22;21:677-687. doi: 10.1016/j.csbj.2022.12.036. eCollection 2023.
3
Chitinase-3 like-protein-1 promotes glioma progression via the NF-κB signaling pathway and tumor microenvironment reprogramming.
一种基于数据中心的机器学习方法,用于利用低失衡 TCGA 数据改善脑胶质瘤分级预测。
Sci Rep. 2024 Jul 26;14(1):17195. doi: 10.1038/s41598-024-68291-0.
几丁质酶 3 样蛋白 1 通过 NF-κB 信号通路和肿瘤微环境重编程促进胶质瘤的进展。
Theranostics. 2022 Oct 3;12(16):6989-7008. doi: 10.7150/thno.75069. eCollection 2022.
4
Pyroptosis-related gene expression patterns and corresponding tumor microenvironment infiltration characterization in ovarian cancer.卵巢癌中焦亡相关基因表达模式及相应肿瘤微环境浸润特征
Comput Struct Biotechnol J. 2022 Sep 28;20:5440-5452. doi: 10.1016/j.csbj.2022.09.037. eCollection 2022.
5
TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing.TRIM67 通过 Rho GTPase 依赖性膜泡形成促进少突胶质细胞瘤的肿瘤发生。
Neuro Oncol. 2023 Jun 2;25(6):1031-1043. doi: 10.1093/neuonc/noac233.
6
Identification of new head and neck squamous cell carcinoma subtypes and development of a novel score system (PGSscore) based on variations in pathway activity between tumor and adjacent non-tumor samples.鉴定新的头颈部鳞状细胞癌亚型,并基于肿瘤与相邻非肿瘤样本之间通路活性的差异开发一种新的评分系统(PGSscore)。
Comput Struct Biotechnol J. 2022 Sep 1;20:4786-4805. doi: 10.1016/j.csbj.2022.08.057. eCollection 2022.
7
Glioma stem cell signature predicts the prognosis and the response to tumor treating fields treatment.胶质母细胞瘤干细胞标志物可预测预后和对肿瘤治疗电场治疗的反应。
CNS Neurosci Ther. 2022 Dec;28(12):2148-2162. doi: 10.1111/cns.13956. Epub 2022 Sep 7.
8
Single-cell multimodal analysis identifies common regulatory programs in synovial fibroblasts of rheumatoid arthritis patients and modeled TNF-driven arthritis.单细胞多模态分析鉴定类风湿关节炎患者滑膜成纤维细胞和模拟 TNF 驱动的关节炎中的共同调控程序。
Genome Med. 2022 Jul 26;14(1):78. doi: 10.1186/s13073-022-01081-3.
9
Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy.低级别胶质瘤中与复发和恶性进展相关的生物标志物及其在免疫治疗中的作用。
Front Immunol. 2022 May 23;13:899710. doi: 10.3389/fimmu.2022.899710. eCollection 2022.
10
Exaggerated false positives by popular differential expression methods when analyzing human population samples.分析人类群体样本时,常用差异表达方法会导致假阳性结果夸大。
Genome Biol. 2022 Mar 15;23(1):79. doi: 10.1186/s13059-022-02648-4.